Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
Dupuis C, Mercier C, Yang C, Monjanel-Mouterde S, Ciccolini J, Fanciullino R, Pourroy B, Deville JL, Duffaud F, Bagarry-Liegey D, Durand A, Iliadis A, Favre R. Dupuis C, et al. Among authors: bagarry liegey d. Anticancer Drugs. 2008 Mar;19(3):267-73. doi: 10.1097/cad.0b013e3282f21376. Anticancer Drugs. 2008. PMID: 18510172
Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities.
Mercier C, Ciccolini J, Pourroy B, Fanciullino R, Duffaud F, Digue L, Tranchand B, Monjanel-Mouterde S, Guillet P, Nicoara A, Baciuchka M, Bagarry-Liegey D, Lacarelle B, Noble A, Durand A, Favre R. Mercier C, et al. Among authors: bagarry liegey d. Ther Drug Monit. 2006 Apr;28(2):212-8. doi: 10.1097/01.ftd.0000198646.32128.ef. Ther Drug Monit. 2006. PMID: 16628133
DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity.
Yang CG, Ciccolini J, Blesius A, Dahan L, Bagarry-Liegey D, Brunet C, Varoquaux A, Frances N, Marouani H, Giovanni A, Ferri-Dessens RM, Chefrour M, Favre R, Duffaud F, Seitz JF, Zanaret M, Lacarelle B, Mercier C. Yang CG, et al. Among authors: bagarry liegey d. Cancer Chemother Pharmacol. 2011 Jan;67(1):49-56. doi: 10.1007/s00280-010-1282-4. Epub 2010 Mar 5. Cancer Chemother Pharmacol. 2011. PMID: 20204365 Clinical Trial.
[Nutritional workshops for cancer patients: a pilot approach].
Mouysset JL, Baciuchka-Palmaro M, Ichou M, Duffaud F, Neulat G, Dudoit E, Bagarry-Liegey D, Tramoni M, Spiegel D, Marco JL, Favre R. Mouysset JL, et al. Among authors: bagarry liegey d. Bull Cancer. 2001 Oct;88(10):959-64. Bull Cancer. 2001. PMID: 11713033 Free article. French.
[Clinical pilot study on repeated use of heparin, vancomycin, colimycine locked flush solution for central intravenous implanted catheter in oncology].
Guillet P, La Scola B, Bagarry-Liegey D, Lorvellec K, Martin N, Nicoara A, Baciuchka M, Duffaud F, Carissimi P, Cohen P, Delorme J, Carle G, Braguer D, Quilichini F, Crevat A, Favre R. Guillet P, et al. Among authors: bagarry liegey d. Pathol Biol (Paris). 1997 Jun;45(6):506-13. Pathol Biol (Paris). 1997. PMID: 9309269 French.
High-dose methotrexate: a clinical and pharmacokinetic evaluation. Treatment of advanced squamous cell carcinoma of the head and neck using a prospective mathematical model and pharmacokinetic surveillance.
Favre R, Monjanel S, Alfonsi M, Pradoura JP, Bagarry-Liegey D, Clement S, Imbert AM, Lena N, Colonna d'Istria J, Cano JP, Carcassonne Y. Favre R, et al. Among authors: bagarry liegey d. Cancer Chemother Pharmacol. 1982;9(3):156-60. doi: 10.1007/BF00257744. Cancer Chemother Pharmacol. 1982. PMID: 7160050
Maintenance chemoimmunotherapy of nonlymphoblastic acute leukemias.
Favre R, Sebahoun G, Bagarry-Liégey D, Imbert C, Ciardelli P, Gastaut JA, Meyer G, Carcassonne Y. Favre R, et al. Recent Results Cancer Res. 1982;80:56-63. doi: 10.1007/978-3-642-81685-7_9. Recent Results Cancer Res. 1982. PMID: 7036297 Clinical Trial.
12 results